Your browser doesn't support javascript.
loading
The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro.
Matalon, Shay; Palmer, Brent E; Nold, Marcel F; Furlan, Antonio; Kassu, Afework; Fossati, Gianluca; Mascagni, Paolo; Dinarello, Charles A.
Affiliation
  • Matalon S; Department of Medicine, University of Colorado Denver, 12700 E. 19th Avenue B-168, Aurora, CO 80045, USA.
J Acquir Immune Defic Syndr ; 54(1): 1-9, 2010 May 01.
Article in En | MEDLINE | ID: mdl-20300007
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / CD4-Positive T-Lymphocytes / HIV-1 / Receptors, CXCR4 / Histone Deacetylase Inhibitors / CCR5 Receptor Antagonists / Hydroxamic Acids Limits: Humans Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2010 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / CD4-Positive T-Lymphocytes / HIV-1 / Receptors, CXCR4 / Histone Deacetylase Inhibitors / CCR5 Receptor Antagonists / Hydroxamic Acids Limits: Humans Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2010 Document type: Article Affiliation country: Country of publication: